217 related articles for article (PubMed ID: 34706681)
1. Both the serum AFP test and AFP/GPC3/SALL4 immunohistochemistry are beneficial for predicting the prognosis of gastric adenocarcinoma.
Wang B; Xie Y; Zheng L; Zheng X; Gao J; Liu X; Yuan Y; Li Z; Lu N; Xue L
BMC Gastroenterol; 2021 Oct; 21(1):408. PubMed ID: 34706681
[TBL] [Abstract][Full Text] [Related]
2. SALL4 represents fetal gut differentiation of gastric cancer, and is diagnostically useful in distinguishing hepatoid gastric carcinoma from hepatocellular carcinoma.
Ushiku T; Shinozaki A; Shibahara J; Iwasaki Y; Tateishi Y; Funata N; Fukayama M
Am J Surg Pathol; 2010 Apr; 34(4):533-40. PubMed ID: 20182341
[TBL] [Abstract][Full Text] [Related]
3. Colorectal adenocarcinoma with enteroblastic differentiation: a clinicopathological study of five cases.
Murakami T; Yao T; Yatagai N; Yamashiro Y; Saito T; Sakamoto N; Nagahara A
Histopathology; 2020 Jan; 76(2):325-332. PubMed ID: 31429980
[TBL] [Abstract][Full Text] [Related]
4. Expression of RNA-binding protein LIN28 in classic gastric hepatoid carcinomas, gastric fetal type gastrointestinal adenocarcinomas, and hepatocellular carcinomas: An immunohistochemical study with comparison to SALL4, alpha-fetoprotein, glypican-3, and Hep Par1.
Zhao M; Sun L; Lai JZ; Shi H; Mei K; He X; Jin X; Lai J; Cao D
Pathol Res Pract; 2018 Oct; 214(10):1707-1712. PubMed ID: 30196987
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathologic and immunohistochemical characteristics of gastric adenocarcinoma with enteroblastic differentiation: a study of 29 cases.
Murakami T; Yao T; Mitomi H; Morimoto T; Ueyama H; Matsumoto K; Saito T; Osada T; Nagahara A; Watanabe S
Gastric Cancer; 2016 Apr; 19(2):498-507. PubMed ID: 25893262
[TBL] [Abstract][Full Text] [Related]
6. [Gastric adenocarcinoma with enteroblastic differentiation and elevated serum alpha fetoprotein].
Li QZ; Zhao HB; Ban N; Wang Q; Zhang JJ; Ding SN; Li HH; Zhou ZH
Zhonghua Bing Li Xue Za Zhi; 2020 Sep; 49(9):886-890. PubMed ID: 32892552
[No Abstract] [Full Text] [Related]
7. Fetal gut-like differentiation in gallbladder cancer.
Koyama K; Maeda D; Tamura D; Narita C; Kudo-Asabe Y; Sato T; Yamamoto Y; Sageshima M; Nanjo H; Goto A
Hum Pathol; 2017 Dec; 70():27-34. PubMed ID: 28970139
[TBL] [Abstract][Full Text] [Related]
8. [Clinicopathological features of gastric alpha-fetoprotein-producing adenocarcinoma with SWI/SNF complex deletion].
Yang JZ; Guo XX; Xu C; Hou YY; Yuan W
Zhonghua Bing Li Xue Za Zhi; 2024 Jan; 53(1):52-57. PubMed ID: 38178747
[No Abstract] [Full Text] [Related]
9. Clinicopathological characteristics of gastric adenocarcinoma with enteroblastic differentiation and gastric adenocarcinoma with enteroblastic marker expression.
Abe D; Akazawa Y; Yatagai N; Hayashi T; Ueyama H; Mine S; Fukunaga T; Nagahara A; Yao T; Saito T
Virchows Arch; 2023 Sep; 483(3):405-414. PubMed ID: 37581693
[TBL] [Abstract][Full Text] [Related]
10. Hepatocellular oncofetal protein, glypican 3 is a sensitive marker for alpha-fetoprotein-producing gastric carcinoma.
Hishinuma M; Ohashi KI; Yamauchi N; Kashima T; Uozaki H; Ota S; Kodama T; Aburatani H; Fukayama M
Histopathology; 2006 Nov; 49(5):479-86. PubMed ID: 17064293
[TBL] [Abstract][Full Text] [Related]
11. Integrated clinicopathological and immunohistochemical analysis of gastric adenocarcinoma with hepatoid differentiation: an exploration of histogenesis, molecular characteristics, and prognostic markers.
He F; Fu Y; Sun Q; Geng P; Zheng Z; Pu X; Shi J; Fan X
Hum Pathol; 2021 Sep; 115():37-46. PubMed ID: 33636206
[TBL] [Abstract][Full Text] [Related]
12. [Two cases of gastric cancer expressing Glypican 3, but producing AFP with different lectin affinity].
Oishi C; Baba T; Kubota Y; Shimotsuma Y; Kitamura K; Honma T; Ikegami A; Inokuchi M; Umeda T; Yoshida H; Imawari M
Nihon Shokakibyo Gakkai Zasshi; 2009 Jun; 106(6):805-12. PubMed ID: 19498312
[TBL] [Abstract][Full Text] [Related]
13. Gastric Cancer With Primitive Enterocyte Phenotype: An Aggressive Subgroup of Intestinal-type Adenocarcinoma.
Yamazawa S; Ushiku T; Shinozaki-Ushiku A; Hayashi A; Iwasaki A; Abe H; Tagashira A; Yamashita H; Seto Y; Aburatani H; Fukayama M
Am J Surg Pathol; 2017 Jul; 41(7):989-997. PubMed ID: 28505005
[TBL] [Abstract][Full Text] [Related]
14. Combination of hepatocellular markers is useful for prognostication in gastric hepatoid adenocarcinoma.
Osada M; Aishima S; Hirahashi M; Takizawa N; Takahashi S; Nakamura K; Tanaka M; Maehara Y; Takayanagi R; Oda Y
Hum Pathol; 2014 Jun; 45(6):1243-50. PubMed ID: 24767858
[TBL] [Abstract][Full Text] [Related]
15. Alpha-Fetoprotein (AFP)-Negative Hepatoid Adenocarcinoma of the Stomach and its Associated Uncommon Features With a Review.
Rajasekaran P; Pattnaik B; Mishra M; Shahin M; Mishra P; Ayyanar P
Int J Surg Pathol; 2023 Aug; 31(5):872-878. PubMed ID: 36503302
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic value of serum glypican-3 alone and in combination with AFP as an aid in the diagnosis of liver cancer.
Liu S; Wang M; Zheng C; Zhong Q; Shi Y; Han X
Clin Biochem; 2020 May; 79():54-60. PubMed ID: 32087138
[TBL] [Abstract][Full Text] [Related]
17. A rare case of recurrent alpha-fetoprotein-producing gastric cancer without re-elevation of serum AFP.
Tomiyama K; Takahashi M; Fujii T; Kunisue H; Kanaya Y; Maruyama S; Yokoyama N; Shimizu N; Soda M
J Int Med Res; 2006; 34(1):109-14. PubMed ID: 16604831
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic value of glypican-3 in serum and liver for primary hepatocellular carcinoma.
Liu H; Li P; Zhai Y; Qu CF; Zhang LJ; Tan YF; Li N; Ding HG
World J Gastroenterol; 2010 Sep; 16(35):4410-5. PubMed ID: 20845507
[TBL] [Abstract][Full Text] [Related]
19. Glypican-3 level assessed by the enzyme-linked immunosorbent assay is inferior to alpha-fetoprotein level for hepatocellular carcinoma diagnosis.
Jeon Y; Jang ES; Choi YS; Kim JW; Jeong SH
Clin Mol Hepatol; 2016 Sep; 22(3):359-365. PubMed ID: 27729630
[TBL] [Abstract][Full Text] [Related]
20. Clinical implications of alpha-fetoprotein expression in gastric adenocarcinoma.
Chen J; Röcken C; Treiber G; Jentsch-Ulrich K; Malfertheiner P; Ebert MP
Dig Dis; 2003; 21(4):357-62. PubMed ID: 14752227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]